MB, Levis & Associates’s CME Group CME Stock Holding History

MB, Levis & Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-210	Closed	-$57.9K	–	261
2025 Q2	$57.9K	Hold	210	–	–	0.03%	116
2025 Q1	$55.7K	Buy	210 +5	+2%	+$1.23K	0.03%	115
2024 Q4	$47.5K	Buy	205 +1	+0.5%	+$230	0.02%	119
2024 Q3	$44.9K	Buy	204 +1	+0.5%	+$207	0.02%	123
2024 Q2	$39.8K	Buy	203 +2	+1%	+$413	0.02%	124
2024 Q1	$43.4K	Buy	201 +6	+3%	+$1.26K	0.02%	120
2023 Q4	$41.1K	Buy	195 +1	+0.5%	+$213	0.02%	121
2023 Q3	$38.9K	Buy	194 +1	+0.5%	+$199	0.03%	127
2023 Q2	$35.8K	Buy	193 +1	+0.5%	+$185	0.02%	136
2023 Q1	$36.8K	Buy	192 +55	+40%	+$9.95K	0.03%	134
2022 Q4	$23.1K	Buy	+137	New	+$23.8K	0.02%	141

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MB, Levis & Associates's CME Position: Q3 2025 in Review

MB, Levis & Associates sold out of CME Group (CME) in Q3 2025, closing a stake of 210 shares — an estimated $57.9K sold.

MB, Levis & Associates first reported a position in CME in Q4 2022 and held it in 11 quarters. The position peaked at $57.9K in Q2 2025. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

MB, Levis & Associates reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
MB, Levis & Associates sold 210 CME Group shares in Q3 2025, an estimated $57.9K.
MB, Levis & Associates first reported a position in CME Group in Q4 2022 and held it in 11 quarters.
MB, Levis & Associates's CME Group position peaked at $57.9K in Q2 2025.
1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.